Publication | Closed Access

Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study

Lymphoid NeoplasiaOncologyRefractory HodgkinPathologyAnaplastic Large-cell LymphomaCancer TreatmentAdult T-cell Leukemia-lymphomaMedicineCancer ResearchBrentuximab Vedotin